My concern is that UNCY …like GERN…see my previous post….has one product olc current and one more in the pipeline but probably years away…if UNCY doesn’t get product in clinics asap like you mentioned that’s problem 1…problem 2 it appears they may Gia initially not having a partner that has self space already in clinics to get the word out….problem 3 the longer they wait for a buyout the possibility…like GERN…olc isn’t creating revenue, growth, profits as expected….thus turning off someone from buying them….you said $50-$60 long term…boy with the shares I got that would be sweet…maybe even two happy meals each…but get me $30-$40 sooner to be safe ….again refer to GERN
Market Data 
Markets 
AI
